Species, sex and inter-individual differences in DNA repair induced by nine sex steroids in primary cultures of rat and human hepatocytes

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 536, Issue 1-2, 2003, Pages 69-78

  Martelli, Antonietta ^a   Mattioli, Francesca ^a   Angiola, Marianna ^a   Reimann, Roland ^b   Brambilla, Giovanni ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b BAYER PHARMA AG   (Germany)

Author keywords

DNA repair synthesis; Primary human hepatocytes; Primary rat hepatocytes; Sex steroids

Indexed keywords

DROSPIRENONE; ETHINYLESTRADIOL; MEDROXYPROGESTERONE; METHYLTESTOSTERONE; NORETHISTERONE; OXYMETHOLONE; PROGESTERONE; STANOZOLOL; TESTOSTERONE; TOXIC SUBSTANCE;

ANIMAL CELL; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; CYTOTOXICITY; DNA REPAIR; DNA SYNTHESIS; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; LIVER CELL CULTURE; MALE; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENTIATION;

EID: 0037457572     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(03)00036-6     Document Type: Article

References (39)

1. M. Lehmann, B. Putz, H.A. Poggel, P. Günzel, Experimental toxicity studies with contraceptive steroids and their relevance for human risk estimation, in: A.D. Dayan, A.J., Paine (Eds.), Advances in Applied Toxicology, Taylor & Francis, London, 1989, pp. 51-79.
2. International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans, Supplement 7: Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs, vols. 1-42, IARC, Lyon, France, 1987, pp. 96-97 and 273-310.
3. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 72, Hormonal Contraception and Post-Menopausal Hormonal Therapy, IARC, Lyon, France, 1999.
4. Schulte-Hermann R., Ohde G., Schuppler J., Timmermann-Trosiener I. Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin. Cancer Res. 41:1981;2256-2262.
5. Ochs H., Düsterberg B., Günzel P., Schulte-Hermann R. Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver. Cancer Res. 46:1986;1224-1232.
6. Schulte-Hermann R., Ochs H., Bursch W., Parzefall W. Quantitative structure-activity studies on effects of sixteen different steroids on growth and monooxygenases of rat liver. Cancer Res. 48:1988;2462-2468.
7. Lang R., Redmann U. Non-mutagenicity of some sex hormones in the Ames Salmonella microsome mutagenicity test. Mutat. Res. 67:1979;361-365.
8. International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risks to Humans. Supplement 6: Genetic and Related Effects: An Updating of Selected IARC Monographs, vols. 1-42, IARC, Lyon, France, 1987.
9. Lang R., Reimann R. Studies for a genotoxic potential of some endogenous and exogenous sex steroids. I. Communication: examination for the induction of gene mutations using the Ames Salmonella/microsome test and the HGPRT test in V 79 cells. Environ. Mol. Mutagen. 21:1993;272-304.
10. Reimann R., Kalweit S., Lang R. Studies for a genotoxic potential of some endogenous and exogenous sex steroids. II. Communication: examination for the induction of cytogenetic damage using the chromosomal aberration assay on human lymphocytes in vitro and the mouse bone marrow micronucleus test in vivo. Environ. Mol. Mutagen. 28:1996;133-144.
11. Topinka J., Andrae U., Schwarz L.R., Wolff T. Cyproterone acetate generates DNA adducts in rat liver and in primary rat hepatocytes cultures. Carcinogenesis. 14:1993;423-427.
12. Martelli A., Mattioli F., Fazio S., Andrae U., Brambilla G. DNA repair synthesis and DNA fragmentation in primary cultures of human and rat hepatocytes exposed to cyproterone acetate. Carcinogenesis. 16:1995;1265-1269.
13. Werner S., Kunz S., Beckurts T., Heidecke C.D., Wolff T., Schwarz L.R. Formation of DNA adducts by cyproterone acetate and some structural analogues in primary cultures of human hepatocytes. Mutat. Res. 395:1997;179-187.
14. Werner S., Topinka J., Wolff T., Schwarz L.R. Accumulation and persistence of DNA adducts of the synthetic steroid cyproterone acetate in rat liver. Carcinogenesis. 16:1995;2369-2372.
15. Martelli A., Brambilla Campart G., Ghia M., Allavena A., Mereto E., Brambilla G. Induction of micronuclei and initiation of enzyme-altered foci in the liver of female rats treated with cyproterone acetate, chlormadinone acetate or megestrol acetate. Carcinogenesis. 17:1996;551-554.
16. Deml E., Schwarz L.R., Oesterle D. Initiation of enzyme-altered foci by the synthetic steroid cyproterone acetate in rat liver foci bioassay. Carcinogenesis. 14:1993;1229-1231.
17. Krebs O., Schäfer B., Wolff T.H., Oesterle D., Deml E., Sund M., Favor J. The DNA damaging drug cyproterone acetate causes gene mutations and induces glutathione-S-transferase P in the liver of female Big Blue™ transgenic F344 rats. Carcinogenesis. 19:1998;241-245.
18. Kerdar R.S., Baumann A., Brudny-Klöppel M., Biere H., Blode H., Kuhnz W. Identification of 3α-hydroxy-cyproterone acetate as a metabolite of cyproterone acetate in the bile of female rats and the potential of this and other already known or putative metabolites to form DNA adducts in vitro. Carcinogenesis. 16:1995;1835-1841.
19. Werner S., Kunz S., Wolff T., Schwarz L.S. Steroidal drug cyproterone acetate is activated to DNA-binding metabolites by sulfonation. Cancer Res. 56:1996;4391-4397.
20. The Collaborative MILTS Project Team, Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS), Contraception 56 (1997) 275-284.
21. Heinemann L.A.J., Will-Shahab L., van Kesteren P., Gooren L.J.G. The Collaborative Centres, Safety of cyproterone acetate: report of active surveillance. Pharmacoepidemiol. Drug Safety. 6:1997;169-178.
22. Watanabe S., Cui Y., Tanae A., Tanaka T., Fujimoto M., Matsuo Y., Tachibana K., Yamasaki S. Ad hoc Committee for CPA. Follow-up study of children with precocious-puberty treated with cyproterone acetate. J. Epidemiol. 7:1997;173-178.
23. Topinka J., Binkova B., Zhu H.K., Andrae U., Neumann I., Schwarz L.R., Werner S., Wolff T. DNA damaging activity of the cyproterone acetate analogues chlormadinone acetate and megestrol acetate in rat liver. Carcinogenesis. 16:1995;1483-1487.
24. Martelli A., Mattioli F., Ghia M., Mereto E., Brambilla G. Comparative study of DNA repair induced by cyproterone acetate chlormadinone acetate and megestrol acetate, in primary cultures of human and rat hepatocytes. Carcinogenesis. 17:1996;1153-1156.
25. 32P -postlabeling technique Pharmacol. Toxicol. 78:1996;214-223.
26. Probst G.S., McMahon R.E., Hill E.E., Thompson C.Z., Epp J.K., Neal S.B. Chemically-induced unscheduled DNA synthesis in primary rat hepatocyte cultures. A comparison with bacterial mutagenicity using 218 compounds. Environ. Mutagen. 3:1981;11-32.
27. Williams G.M., Mori H., McQueen C.A. Structure-activity relationships in the rat hepatocyte DNA repair test for 300 chemicals. Mutat. Res. 221:1989;263-286.
28. Williams G.M. Detection of chemical carcinogens by unscheduled DNA synthesis in rat liver primary cell cultures. Cancer Res. 37:1977;1845-1851.
29. Strom S.C., Jirtle R.L., Jones R.S., Novicki D.L., Rosenberg M.R., Novotny A., Irons G., McLain J.R., Michalopoulos G. Isolation, culture, and transplantation of human hepatocytes. J. Natl. Cancer Inst. 68:1982;771-778.
30. Madle S., Dean S.W., Andrae U., Brambilla G., Burlinson B., Doolittle D.J., Furihata C., Hertner T., McQueen C.A., Mori H. Recommendations for the performance of UDS tests in vitro and in vivo. Mutat. Res. 312:1994;263-285.
31. Lonati-Galligani M., Lohman P.H.M., Berends F. The validity of the autoradiographic method for detecting DNA repair synthesis in rat hepatocytes in primary culture. Mutat. Res. 113:1983;145-160.
32. C. Dollery, Therapeutic Drugs, Churchill Livingstone, Edinburg, 1991.
33. Blakey D.C., White I.N.H. Unscheduled DNA synthesis caused by norethindrone and related contraceptive steroids in short-term male rat hepatocyte cultures. Carcinogenesis. 8:1985;1201-1205.
34. Seraj M.J., Umemoto A., Tanaka M., Kajikawa A., Hamada K., Monden Y. DNA adducts formation by hormonal steroids in vitro. Mutat. Res. 370:1996;49-59.
35. Feser W., Kerdar R.S., Baumann A., Körber J., Blode H., Kuhnz W. DNA adduct formation of selected sex steroids in human liver slices in vitro. Toxicol. In Vitro. 12:1998;353-364.
36. Martelli A., Mattioli F., Carrozzino R., Ferraris E., Marchese M., Angiola M., Brambilla G. Genotoxicity of potassium canrenoate in cultured rat and human cells. Mutagenesis. 14:1999;465-472.
37. Watanabe S., Yamasaky S., Tanae A., Ibi I., Honna T. Three cases of hepatocellular carcinoma among cyproterone users. Lancet. 344:1994;1567-1568.
38. Ohri S.K., Gaer J.A.R., Keane P.F. Hepatocellular carcinoma and treatment with cyproterone acetate. Br. J. Urol. 67:1991;213.
39. Rüdiger T., Beckmann J., Queisser W. Hepatocellular carcinoma after treatment with cyproterone acetate combined with ethinyl-oestradiol. Lancet. 345:1995;452-453.